Clinical characteristics of 91 individuals with critical demyelinating lesions
| Clinical Characteristics | |
|---|---|
| Demographics | |
| Female sex (No.) (%) | 51 (56%) |
| White ethnicity (No.) (%) | 88 (97%) |
| Median age at first symptom (range) (yr) | 50 (28–65) |
| Median age at last MR imaging (range) (yr) | 58 (36–80) |
| Median age at progression (range) (yr) | 52 (30–73) |
| Clinical course (No.) (%) | |
| Progression from onset (primary-progressive) | 56/91 (62%) |
| Relapse onset (secondary-progressive) | 25/91 (28%) |
| Clinical cohort (No.) (%) | |
| PUHMS | 37 (41%) |
| PPS | 35 (38%) |
| PSS | 19 (21%) |